Nektar Therapeutics: Q4 Earnings Insights

Nektar Therapeutics NKTR reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Nektar Therapeutics beat estimated earnings by 2.47%, reporting an EPS of $-0.79 versus an estimate of $-0.81.

Revenue was up $1.55 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.1 which was followed by a 19.22% drop in the share price the next day.

Here's a look at Nektar Therapeutics's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.